Related Experiment Video
Updated: Jul 23, 2025

05:31
Transradial Access Chemoembolization for Hepatocellular Carcinoma Patients
Published on: September 20, 2020
5.6K
Combining Immunotherapy with Transarterial Radioembolization
Zeynep Ceren Balaban Genc1, Efe Soydemır2, Seval Ay Ersoy3
1Department of Nuclear Medicine, Pendik Training and Research Hospital, Marmara University, Istanbul, Turkey.
Summary
This case report shows that combining transarterial radioembolization with immunotherapy (atezolizumab and bevacizumab) is an effective treatment strategy for advanced hepatocellular carcinoma (HCC). This combination offers a promising approach for managing this challenging cancer.
Area of Science:
- Hepatology
- Oncology
- Radiology
Background:
- Hepatocellular carcinoma (HCC) presents a significant global health challenge with high mortality rates.
- Late-stage diagnosis and limited efficacy of conventional therapies necessitate novel treatment strategies for unresectable HCC.
Related Concept Videos
Tumor Immunotherapy
567
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
567
Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K

